COLLABRX INC
Enterprise healthcare data infrastructure platform combining blockchain immutability with AI-driven clinical insights
- Sector
- Digital health
- Headquarters
- PALO ALTO, CA
- Founded
- 2008
- Latest Form D
- $1.6M, Apr 2011
- Total capital
- $3.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.1M
- 2 Form D · last Apr 2011
- 187 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$1.6M
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Amos BarzilayExecutive Officer, DirectorNamed in SEC Form D filings
- Barry G. NewmanDirectorNamed in SEC Form D filings
- Gavin J. GordonExecutive OfficerNamed in SEC Form D filings
- George D. LundbergExecutive OfficerNamed in SEC Form D filings
- Jay M. TenenbaumExecutive Officer, DirectorNamed in SEC Form D filings
- Jeff M. ShragerExecutive OfficerNamed in SEC Form D filings
Show all 9 people
- John G. CurdDirectorNamed in SEC Form D filings
- Robert RodinDirectorNamed in SEC Form D filings
- Smruti D. VidwansExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingActionability framework for genomic biomarkerUSPTOApplication 14730228
- PendingAn Actionability Framework For Genomic BiomarkerUSPTOApplication PCTUS2015044408
- PendingMethod To Treat Braf Inhibitor-resistant SubjectsUSPTOApplication PCTUS2011049432
Show all 4 patent records
- Actionability framework for genomic biomarkerDec 3, 2015 · Application 14730228Pending
- An Actionability Framework For Genomic BiomarkerApplication PCTUS2015044408Pending
- Method To Treat Braf Inhibitor-resistant SubjectsApplication PCTUS2011049432Pending
- Individualized Cancer TreatmentApplication PCTUS2009065011Pending
Related companies, and why
- Cure, Inc.Similar federal contract value in Digital health · null in contracts
- Decisio Health, Inc.Similar federal contract value in Digital health · null in contracts
- 1health.io Inc..Similar federal contract value in Digital health · null in contracts
- ThetaRho, Inc.Similar federal contract value in Digital health · null in contracts
- Medical Search Technologies Inc.Similar federal contract value in Digital health · null in contracts
- TERANODE CORPSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .